FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to the field of medicine and pharmacy. The pharmaceutical composition includes Dimephosphon (dimethyl-oxobutyl-phosphonyl-dimethylat), Calcium Carbonate and Magnesium Mycellat substance, excipients and water with the following component ratio, w/w%: Dimephosphon - 1.0-20.0, Calcium Carbonate and Magnesium Mycellat substance - 1.0-10.0, excipients - 6.0-18.0, water - the remaining w/w %. The composition has a significant specific pharmacological effect demonstrating nootropic activity, does not produce a significant general toxic effect with different doses and routes of administration in experimental animals, does not have irritating and sensibilizing effects.
EFFECT: composition is an effective and safe product and can be used for normalization of central nervous system neurometabolic and cerebroprotective properties, as well as brain mental and mnestic functions, including those in patients with diabetes mellitus.
3 cl, 1 tbl, 1 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION 'MYCEPHOSPHONE' FOR STIMULATION OF SUPPORTING TISSUE REGENERATION | 2010 |
|
RU2442592C1 |
| PHARMACEUTICAL COMPOSITION 'MYCENORM' WITH ANTACIDIC ACTION | 2010 |
|
RU2442591C1 |
| PHARMACEUTICAL COMPOSITION 'MYCESLAVINE' WITH ANTI-SHOCK AND ANTI-ALLERGIC ACTION (VARIANTS) | 2010 |
|
RU2442590C1 |
| PHARMACEUTICAL COMPOSITION MYCEOSTIN STIMULATING SUPPORTING TISSUE AND ARTICULAR CARTILAGE REGENERATION (VERSIONS) | 2010 |
|
RU2444365C1 |
| MEDICINAL AGENT POSSESSING NOOTROPIC ACTIVITY (VARIANTS) | 2006 |
|
RU2322240C1 |
| SOLID DOSAGE FORMS WITH CHOLINE-POSITIVE ACTION BASED ON 9-BUTYLAMINO-3,3-DIMETHYL-1,2,4-TRIHYDROACRIDINE | 2016 |
|
RU2616247C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION, HAVING NOOTROPIC ACTIVITY | 2018 |
|
RU2703293C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
